Our two-fold mission is to improve the quality of human life through creative basic and translational research in cardiovascular disease, and to build a legacy of outstanding scholarship, scientific achievement, and therapeutic discovery. We will accomplish our mission by providing a challenging, results-oriented environment for training and developing future generations of researchers and physician-scientists.
Recent NewsDecember 12, 2011
FCVRI researcher discovers gene that may lead to new therapies for blindness-causing eye diseases Dr. Tsutomu Kume, an investigator at Feinberg Cardiovascular Research Institute, in collaboration with colleagues at University of Alberta, discovered that FoxC1 regulates vascularization of the cornea. Loss of the FoxC1 gene led to excessive corneal vascularization. It was hypothesized that increasing the levels of FoxC1 may represent a potential new therapeutic approach to treating multiple eye diseases manifested by overvascularization, which leads to diminished vision and blindness. More information about their discovery can be found here. Dr. Kume's research was accepted for publication in a forthcoming issue of Proceedings of the National Academy of Sciences. November 18, 2011
FCVRI researcher wins prestigious Melvin Marcus Young Investigator Award from American Heart Association Melissa Thal, PhD, a Postdoctoral Fellow working under the mentorship of Dr. Raj Kishore, was awarded the Melvin Marcus Young Investigator Award at the American Heart Association's Scientific Sessions held in Orlando, Florida. This prestigious competitive award is given annually to early career investigators who have demonstrated outstanding research based on submitted manuscript and presentation at the competition. We offer our congratulations to Dr. Thal on her outstanding achievement. 
September 16, 2011
Research paper from Feinberg Cardiovascular Research Institute featured on the cover of Circulation Research A research paper entitled "Exosomes from Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine Activity" was featured on the cover of the September 16, 2011 issue of Circulation Research. The article can be viewed by following this link or by clicking on the image below. 
August 5, 2011
FCVRI researcher wins Outstanding Early Career Investigator Award from American Heart Association Dr. Prasanna Krishnamurthy, a Research Assistant Professor working under the mentorship of Dr. Raj Kishore, was awarded the Outstanding Early Career Investigator Award at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions held in New Orleans, Lousiana. This presigious award is given annually to emerging research investigators who have demonstrated outstanding research. A downloadable copy of his scientific presentation can be found by following this link. We offer our congratulations to Dr. Krishnamurthy. July 7, 2011
Results from a clinical study of autologous adult stem cells for treatment of chronic angina published in Circulation Research The results of a Phase 2 clinical trial evaluating the efficacy and safety of autologous CD34+ cells for treatment of chronic angina was published in Circulation Research today. Dr. Douglas Losordo, Director of Feinberg Cardiovascular Research Institute, was the Principal Investigator of the study. The article can be retrieved by following this link. February 7, 2011
Los Angeles Times article discusses the use of adult stem cells in cardiovascular regenerative medicine An article in Los Angeles Times discusses current research in the field of cardiovascular regenerative medicine, including an interview with Dr. Douglas Losordo, Director of the Feinberg Cardiovascular Research Institute. January 15, 2011
Feinberg Cardiovascular Research Institute investigator receives new grant award from NHLBI Dr. Raj Kishore, Associate Professor of Medicine and an Investigator at Feinberg Cardiovascular Research Institute, received a new R01 grant award from the National Heart, Blood & Lung Institute (NHLBI). The grant, entitled "Effect of Chronic Alcohol on Ischemic Injury and Endothelial Cells", will provide over $1.5 million of research support over a four year period. We wish to congratulate Dr. Kishore on his achievement.
| 
